Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 32

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT00000216Phase 3Completed
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000311Phase 3Completed
Combining Behavioral Treatment With Agonist Maintenance - 1
Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000318Phase 2Completed
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000319Phase 2Completed
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00023283Phase 2Completed
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
Heroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related DisordersHeroin Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score24%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin DependenceCocaine-Related Disorders+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score24%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Related
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related DisordersHeroin Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score24%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score18%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Related
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Yale University
Similarity Score18%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Frederick Altice, MD

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Yale University
Similarity Score12%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Yale University
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00000216Phase 3PrincipalInvestigator

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000311Phase 3PrincipalInvestigator

Combining Behavioral Treatment With Agonist Maintenance - 1

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000318Phase 2PrincipalInvestigator

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000319Phase 2PrincipalInvestigator

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00023283Phase 2PrincipalInvestigator

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Heroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous
Completed

All 5 trials loaded